Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2025

Aug 27, 2025

BUY
$2.63 - $3.77 $53,126 - $76,154
20,200 New
20,200 $53,000
Q1 2025

May 15, 2025

SELL
$2.63 - $3.77 $53,652 - $76,908
-20,400 Reduced 50.25%
20,200 $53,000
Q3 2024

Nov 14, 2024

BUY
$3.24 - $6.19 $131,544 - $251,314
40,600 New
40,600 $136,000

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $3.98M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.